Skip to main content

CITIGROUP INC

Position in ESPR — Esperion Therapeutics, Inc.

CIK 831001 NEW YORK, NY

Position in ESPR

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$0
+$0 QoQ
Shares Held
384,261
+187.6% QoQ
Ownership
0.149%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ESPR Over Time

Shares Held

Position Value (USD)

Derivatives in ESPR

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
173,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $573,447,136 across 59 Drug Manufacturers - Specialty & Generic names. ESPR ranks #59 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ESPR

Export CSV
40 filing rows on record
Report Date Value (USD) Shares
2026-06-30 384,261
2026-03-31 133,596
2026-03-31 173,500
2025-12-31 121,094
2025-09-30 57,112
2025-06-30 80,054
2025-03-31 186,645
2024-12-31 192,123
2024-12-31 127,800
2024-09-30 127,800
2024-09-30 166,004
2024-06-30 50,031
2024-06-30 127,800
2024-03-31 356,748
2024-03-31 200,000
2023-12-31 2,700
2023-12-31 377,991
2023-09-30 14,933
2023-06-30 15,209
2023-03-31 39,928
2022-12-31 15,671
2022-09-30 13,052
2022-06-30 5,021
2022-03-31 3,444
2021-12-31 14,641
2021-09-30 5,085
2021-06-30 153,373
2021-03-31 165,031
2020-12-31 37,300
2020-12-31 15,700
2020-12-31 11,062
2020-09-30 12,200
2020-09-30 38,000
2020-09-30 17,044
2020-06-30 7,200
2020-06-30 32,100
2020-06-30 44,882
2020-03-31 25,400
2020-03-31 8,000
2020-03-31 32,540